Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check10 days agoChange DetectedThe study page displays a 403 Forbidden message with a Home link in place of study content.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the study details, indicating an access restriction or server issue. This changes the visible content from trial information to an error page for the NCT03053050 study.SummaryDifference16%

- Check45 days agoChange DetectedThe page revision updates from v3.6.5 to v3.6.6, indicating a small backend/content adjustment rather than a substantive change to study details or features.SummaryDifference0.0%

- Check52 days agoChange DetectedA new entry, '2016 ( U.S. NIH Grant/Contract )', was added to the list of study identifiers in the 'Other Study ID Numbers' section, indicating NIH funding for the trial.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now presents a full HTML error document indicating the content is temporarily unavailable, replacing the usual study record information on the page. This reflects a site-side issue rather than a content update.SummaryDifference15%

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.